Cisplatin liposomes cut side effects

A pH-sensitive form of liposomal cisplatin could mean better treatment of peritoneal carcinomatosis (where cancers metastasize throughout the lining of the abdomen), with fewer side effects. The liposomes have been designed by Brazilian researchers to release the drug near the tumor, and tests in mice showed better effects against the cancer, with longer survival, as well as fewer side effects on the kidney and bone marrow. Further studies are under way. The results were published in Experimental Biology and Medicine. Press release  | Abstract

Suggested Articles

Purdue's reformulated OxyContin may stop patients from snorting or injecting the drug, but it doesn't curb abuse overall, an FDA panel determined.

Roche is gearing up to launch an eye implant to make its Lucentis AMD drug easier to use. But the drugmaker has even bigger plans for the device.

Delivery specialist IntelGenx struck two deals to develop oral films for prescription psychedelics this summer with Canada's Cybin and ATAI.